| Latest Forum Topics / Healthway Med |
|
|
healthway, healthy?
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
happyharvest
Elite |
23-Mar-2017 22:37
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
It is a GEMS when the company is going bankrupt. when it was not, it is not a GEMS. haha
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
redtree
Member |
23-Mar-2017 22:23
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
At least is some good news... Shall c tmr whether chiong... ☺ ️ | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
tan.leongheng
Member |
23-Mar-2017 18:01
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
AGREES TO REVISED CONVERTIBLE NOTES DEAL WITH SINGAPORE PE FIRM GATEWAY PARTNERS - Deal structure provides immediate as well as longer term capital to Healthway for sustainable growth - Proceeds from first tranche will fund immediate liquidity needs and enable Healthway to fully restore payment schedules for its doctors and suppliers - Gateway to appoint non-executive director to the Healthway board SINGAPORE, 23 March 2017 &ndash Healthway Medical Corporation Limited (&ldquo Healthway&rdquo ) today announced that it has agreed to a revised convertible notes deal with Singapore private equity firm Gateway Partners (&ldquo Gateway&rdquo ), following extensive discussions and amendments to the original proposal. Ms Veronica Chan, President of Healthway, said, &ldquo With the initial tranche of proceeds, our priority is to ensure that our doctors and staff receive their salaries, that our operational issues are resolved, and to continue to take care of our patients. We look forward to having Gateway on board as a long-term partner to support our continued and sustainable growth.&rdquo Mr Khoo Yee Hoe, Chairman of Healthway, added, &ldquo The board and management carried out extensive discussions and reviewed all the details of all the options presented and available to the company, before arriving at a decision that we think best suits the company&rsquo s needs in the circumstances. We understand that this process has taken a fair bit of time. We apologise for the time taken, and appreciate the understanding of our doctors, staff and customers as we move forward.&rdquo Gateway Partners is a Singapore private equity firm focused on investing in South East Asia, South Asia, Middle East and Africa. It has offices in Singapore and Dubai. Under the revised subscription agreement, Healthway will issue Convertible Notes &ldquo B&rdquo (&ldquo CN B&rdquo ) to Gateway for an aggregate principal amount of S$70 million, in two tranches. The first tranche (&ldquo T1 CN B&rdquo ) will comprise S$10 million, while the second tranche (&ldquo T2 CN B&rdquo ) will comprise S$60 million. The Exchange has informed the Company that shareholders&rsquo approval is not required for T1 CN B pursuant to Rule 803 of the Catalist Rules, on the basis that Gateway will nominate one non-executive director to the Healthway board, with the existing board of five members remaining that shareholders&rsquo approval be obtained before Healthway issues T2 CN B that the board not be reconstituted until shareholders&rsquo approval for issuance of T2 CN B is obtained and that Gateway can only exercise its rights under the Negative Covenant after Healthway shareholders approve the issuance of T2 CN B. The S$10 million raised from the T1 CN B will enable Healthway to fulfil its immediate liquidity needs. Healthway will use the proceeds to fund immediate operational needs, including the settlement of salaries and other requirements. The proceeds will also support the restoration of normal payment schedules to its doctors and suppliers. The convertible notes carry no coupon and are redeemable at maturity at 100 percent of the principal amount plus a cash redemption premium payable upon maturity or if an event of default occurs, that will give Gateway a 6% internal rate of return on its principal, for the periods from the respective issue dates of T1 CN B and T2 CN B, to the maturity date. Both tranches of notes mature five years from the issue date of T1 CN B. T1 CN B will be issued on or before 25 March 2017, subject to the receipt of the listing and quotation notice from the Singapore Exchange for the conversion shares issued pursuant to the conversion of T1 CN B. The disbursement of proceeds from the second tranche will take place only after the approval of shareholders for the issuance of T2 CN B. The approval is expected to be sought at an extraordinary general meeting to be held by 21 April 2017. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
mrwise
Supreme |
23-Mar-2017 17:51
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Choinging up tomorrow. All eyeing for a share in this GEMS! Watch! |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
tan.leongheng
Member |
23-Mar-2017 17:43
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
http://infopub.sgx.com/FileOpen/Press%20Release.ashx?App=Announcement& FileID=444372 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
teeth53
Supreme |
23-Mar-2017 17:05
Yells: "don't learn through life, learn to grow with life " |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Err...The dated mayb wrong Saw it ST PAPER - (SUN)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
teeth53
Supreme |
23-Mar-2017 17:02
Yells: "don't learn through life, learn to grow with life " |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Dated 19-03-2017.  This is not guess work.  It print in ST news paper Sun March 26th, 2017.  Fan holding 17% HMC share n on March 8, filed a bankruptcy.  A hearing is scheduled for    April 6, 2017. (9 more working days)  The court will held on to his 17%, if he is adjudged a bankrupt, then the court appointed trustee take over his shares, and will seek a sale to pay to creditors.    |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
newbieinvestor
Member |
23-Mar-2017 16:58
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
you not understand. Fan bankrupt. he owe the $166m. this is the secured or not the secured one? if use the share margin financing is the secured to his HMC share? he sell 17% x $103m = $17.5m. use the $17.5m pay the $166m first. he never direct owe the HMC money. Party A and the Party B is owe HMC money. you try ask the HMC to sue Fan ask pay back loan for the Party A and the Party B. even HMC can win court case also boh lui liao.  
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
teeth53
Supreme |
23-Mar-2017 16:56
Yells: "don't learn through life, learn to grow with life " |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Think it possible (anything is possible), in order to secure their position It has to be 4-days B4 EGM. Who will emerge as the biggest shareholder?.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HB8289
Master |
23-Mar-2017 14:57
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
I think from now till    April 21, 2017 (*Friday).  is anyboby gues where this stock is heading . So the only way is to queue your desire price and hope for the best.  I sure if they will buy whatever price that last few days to secure their position . I my guess. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
teeth53
Supreme |
23-Mar-2017 14:05
Yells: "don't learn through life, learn to grow with life " |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
To me, Lippo also wanted to take total control of Healthway by offering SGD$10m at 5%. The next step after gathering pass 50%, there is chance Lippo will have HMC go private (Mandatory offering also at final price at 0.042c a piece). A chance to delist HMC is also on the card, if n when it gather pass 90%. So It is up to you (small shareholders), it also dependable on SSH (others) to see who is better.  
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
teeth53
Supreme |
23-Mar-2017 13:50
Yells: "don't learn through life, learn to grow with life " |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
If GW proposal is approval, I think can huat abit more. so long trading prices don fall lower then Lippo offering. What you guy think? n/or mkt players will response or react. Tdy reaction by players. some dipping [email protected], while majority trade is done at 0.044 to 0.045c
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
teeth53
Supreme |
23-Mar-2017 13:29
Yells: "don't learn through life, learn to grow with life " |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
I think four days before EGM, to be held on April 21, 2017 (*Friday). Shareholders can decide - To hold / sell n/or vest in....?.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
teeth53
Supreme |
23-Mar-2017 13:22
Yells: "don't learn through life, learn to grow with life " |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Hope. There is some financial share expert here to further elaborate those term. thk in advance.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HB8289
Master |
23-Mar-2017 13:14
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
Meaning to say before  6 April 2017 investor need to decide sell or hold on to face the after math |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
mepkoh
Elite |
23-Mar-2017 13:12
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
feeling uncomfortable about the loans...sold all my hmc shares |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
teeth53
Supreme |
23-Mar-2017 13:07
Yells: "don't learn through life, learn to grow with life " |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
http://pdf.reuters.com/sgxnews/sgxnews.asp?i=43059c3bf0e37541& u=urn:newsml:reuters.com:20170323:nSN33F100 (For full infomation - pls click) On 1st Closing Date (SGD$10m). Subscriber shall have right to appoint one None Exe-Dir nominated. (Subject to Nominating Committee&rsquo s, the Board&rsquo s and Sponsor&rsquo s approval).  Note - 2nd closing. Coy to despatch to Shareholders&rsquo circular for transactions by 6 April 2017 and  convene EGM by 21 April 2017.  (i)  the issuance of  (&ldquo T2 CN B&rdquo ) will comprise a principal amount of S$60 million, and (ii) the exercise of the HME Option at an EGM to be convened. T2 CN B will be disbursed 2 business days after all conditions precedent (2nd Closing Conditions) to disbursement T2 CN B have been fulfilled (and remain valid and in force) and/or waived (if capable of being waived). The Second Closing Conditions include, inter alia:  listing and quotation notice of the SGX-ST for the issuance of the Conversion Shares pursuant to the conversion of T2 CN B having been obtained   (c) The issue of T1 CN B and the completion of the acquisition of HME having occurred   (d) no event causing a material adverse change to the Group having occurred (e) all necessary 3rd party consents in connection with issue of CN B having been obtained and  (f) the issue of the T2 CN B not being prohibited  (1) by any statute, order, rule or regulation promulgated by any legislative, executive or regulatory body or authority of Singapore which is applicable to the Company or  (2) any injunction or other orders issued by any court of competent jurisdiction.  3  The long stop date for the Second Closing Conditions shall be 21 April 2017.  Coy will pledge the shares of all its subsidiaries to Subscriber  to secure, inter alia, obligations of the Coy under both of the T1 CN B and T2 CN B  upon disbursement of T2 CN.  B.  For the avoidance of doubt, in the event that  T2  CN B is not disbursed,  until disbursement of  T2  CN B.  Subscriber shall not have any of the following rights:  (a) Rights to nominate the second NED for appointment   (b) Rights to review the suitability of the IDs in advance of their appointment   (c) Rights to nominate the CFO for appointment or  (d) Rights to consent to appointment of, removal of, or change in role of CEO and CFO.  The above rights shall vest in Subscriber immediately upon disbursement of T2 CN B. Coy shall (subject to receiving relevant approvals) take all such steps as necessary to effect Subscriber&rsquo s nominee as CFO and an additional NED to the Coy on the date of disbursement of T2 CN B.  (vii) The reconstitution of the Board (comprising 2 directors nominated by Subscriber and 2 ind- directors whose suitability shall be reviewed by Subscriber in advance)  shall take place at the AGM  2017, which is  scheduled to take place after the EGM.  (viii) The Coy has to obtain Subscriber&rsquo s prior written consent if it wishes to undertake material transactions, undertakings and corporate actions (Negative Covenant), upon disbursement of the T2 CN B.  In the event that T2 CN B is not disbursed  after the First Closing Date The Coy is not bound by the Negative Covenant. However, Subscriber will have the right to elect not to proceed to disburse either of T1 CN B or T2 CN B should Coy undertake any such material transactions, undertakings and corporate actions prior to the issue of T1 CN B or T2 CN B.  For avoidance of doubt, if such actions occur after T1 CN B has been issued but before issue of T2 CN B, this will not, of itself, constitute an event of default under the conditions of T1 CN B.  (ix) The Coy is required to despatch the Shareholders&rsquo circular for the above transactions by  6 April 2017 and convene the  EGM by 21 April 2017.  In the event that the Coy has exercised its best endeavours but is unable to meet the aforesaid  stipulated timelines, inter alia, due to the approval process by any relevant regulatory authority.  The  parties may mutually agree to extend the time required to meet such timelines.  In the event no mutual agreement is reached, either the Coy or Subscriber may terminate the Amended and Restated Agreement and the parties shall have no further obligations to each other (save for any provisions which survive termination, including the obligation of the Coy to reimburse the Subscriber for costs).  3. APPLICATION OF RULE 803 ON CATALIST RULES. The Exchange has informed Coy that T1 CN B may be issued by the Coy without having obtained Shareholders&rsquo approval pursuant to Rule 803 of the Catalist Rules on the following basis:  4 (a) The Subscriber will nominate 1 NED, with the existing Board of 5 members remaining   (b) Shareholders&rsquo approval will be obtained before the Coy can draw down on T2 CN B   (c) The Board will not be reconstituted until Shareholders&rsquo approval for issuance of T2 CN B is obtained   (d) The Subscriber will only be able to exercise its rights under the Negative Covenant after Shareholders approve the issuance of T2 CN B and  (e) All other key terms (such as reviewing suitability of IDs by the Subscriber, nomination of CFO by the Subscriber, the security pledge and seeking the Subscriber&rsquo s consent for appointment, removal or change of the CEO and CFO) will only apply after Shareholders approve the issuance of T2 CN  B. Accordingly, Coy will be proceeding with the issue of T1 CN B upon the fulfillment and/or waiver of the relevant conditions precedent and will update Shareholders when the same has been completed. The Coy will proceed to convene the extraordinary general meeting (&ldquo EGM&rdquo ) to seek Shareholders&rsquo approval for the issue of T2 CN B at a later date and time to be determined.  A circular containing, inter alia, the notice of the EGM and details in relation to T2 CN B will be despatched to Shareholders in due course.  4.  CONVERSION SHARES T1 CN B  will be issued and allotted pursuant to Share Issue Mandate granted by Shareholders@2016 AGM. Coy had 2,308,236,183 Shares in issue and pursuant to the Share Issue Mandate, the number of Shares that may be issued pursuant to the Share Issue Mandate is 2,308,236,183, of which the maximum number of Shares to be issued other than on a pro rata basis is 1,154,118,091.  The Coy had issued 133,300,000 Shares@an issue price of S$0.03 pursuant to placement exercise completed on 26-09-2016. As such, the remaining number of new Shares that may be issued other than on a pro rata basis is 1,020,818,091.  The number of Conversion Shares to be issued pursuant to the conversion of T1 CN B is 295,508,274, representing approximately 12.01%, existing issued share capital comprising 2,460,234,183 Shares, or 10.72% of the enlarged share capital of 2,755,742,457 Shares.  Accordingly, the allotment and issuance of 295,508,274 T1 CN B Conversion Shares would fall within the limits of the Share Issue Mandate.  Conversion number Shares to be issued pursuant to conversion of T2 CN B  is  1,773,049,645, representing approximately  72.07%  of the Existing Share Capital, or  39.15%  of the enlarged share capital of  4,528,792,102 Shares  (assuming the full conversion of T1 CN B).  Accordingly, the allotment and issuance of 1,773,049,645 T2 CN B Conversion Shares requires the approval of Shareholders under Section 161 of the Companies Act and Rules 803 and 805 of the Catalist Rules.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HB8289
Master |
23-Mar-2017 13:00
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
when is its or how much more to go 
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
mepkoh
Elite |
23-Mar-2017 12:51
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
thats what i understad.. note the infor from sgx... first tranche to beconverted to shares no need shares holder approval... so from this anytime can convert to shares...dyod
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
HB8289
Master |
23-Mar-2017 12:36
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
x 0
x 0 Alert Admin |
look like after wave coming  |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Useful To Me Not Useful To Me | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||

